Allakos Inc. (ALLK)
NASDAQ: ALLK · Real-Time Price · USD
0.2170
-0.0106 (-4.66%)
At close: Apr 1, 2025, 4:00 PM
0.2147
-0.0023 (-1.06%)
After-hours: Apr 1, 2025, 4:28 PM EDT
Allakos Employees
Allakos had 131 employees as of December 31, 2023. The number of employees increased by 8 or 6.50% compared to the previous year.
Employees
131
Change (1Y)
8
Growth (1Y)
6.50%
Revenue / Employee
n/a
Profits / Employee
-$884,107
Market Cap
19.39M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ALLK News
- 20 days ago - Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - Lycia Therapeutics Announces the Appointment of Chin Lee, MD, MPH, as Chief Medical Officer and Reveals Immunology Pipeline - GlobeNewsWire
- 7 weeks ago - Kuehn Law Encourages Investors of Allakos Inc. to Contact Law Firm - GlobeNewsWire
- 2 months ago - Why Is Allakos Stock Plunging On Monday? - Benzinga
- 2 months ago - Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring - GlobeNewsWire
- 5 months ago - Allakos Runs Up Into A Near-Term Catalyst - Seeking Alpha
- 5 months ago - Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 6 months ago - Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - GlobeNewsWire